BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
11. "Aide work for older adults or those living with disabilities. I hate the advertisements and TikToks that make it l
December 19, 2024 3:30 a.m. In November, Oregon’s seasonally adjusted nonfarm payroll employment gained 5,100 jobs, following a revised increase of 3,500 jobs
Guidehouse, a global consulting firm with offices in Austin and Houston, is expanding into San Antonio and plans to create 1,000 jobs in the region over
Last year Governor Maura Healey announced the creation of the Massachusetts Community Climate Bank. The Community Climate Bank is the first example of a “Gree